New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
14:53 EDTHNZ, CMCSA, CSCO, BRK.A, GM, GEMarket set to end week lower after European data disappoints
Stocks are set to end the week slightly lower after bad economic news out of Europe offset positive U.S. economic data and some major developments on the M&A front... MACRO NEWS: GDP in the euro zone and Germany for the fourth quarter dropped and came in below expectations. Japan's Q4 GDP was also worse than expected... Economic data in the U.S. was more upbeat, however, as jobless claims and an index of consumer confidence beat expectations, although industrial production for January was lower than expected... European Central Bank officials indicated that they might impose negative deposit rates on banks' deposits at the central bank... COMPANY NEWS: Comcast (CMCSA) agreed to buy the share of NBC it doesn't already own from GE (GE) and Berkshire Hathaway (BRK.A) and a Brazilian private equity firm agreed to buy H.J. Heinz (HNZ)... In another major deal, Constellation Brands (STZ) announced that it would buy major beer brands, a large brewery in northern Mexico, and other considerations from AB InBev (BUD) for $2.9B. The deal is expected to increase the chances that the Justice Department will allow AB InBev to buy the remaining stake in Mexican brewer Grupo Modelo it doesn't already own... GM (GM) and Cisco (CSCO) both reported stronger than expected quarterly revenues.
News For A;HNZ;GM;CSCO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
May 18, 2015
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
09:54 EDTGMNHTSA looks to accelerate V2V rollout by automakers, Motor Authority says
Automakers have been notified that initial proposals for the implementation of vehicle-to-vehicle technology will be outlined by before January 1, 2016, which would be a full year ahead of schedule, according to Motor Authority. Publicly traded automakers include Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Toyota (TM) and Volkswagen (VLKAY). Mobileye (MBLY) makes chips utilized in advanced driver assistance systems. Reference Link
09:36 EDTCSCOActive equity options trading on open
Subscribe for More Information
06:26 EDTGMStudy shows Toyota and Honda leads in best supplier relations, Reuters says
A new study revealed that Toyota (TM) and Honda (HMC) led automakers with U.S. plants in supplier relations, reports Reuters. According to the study led by Planning Perspectives President John Henke, Toyota led Honda while Ford (F) was a distant third and Nissan (NSANY) came in fourth. General Motors (GM) and Fiat Chrysler (FCAU) were last on the list. Reference Link
May 15, 2015
16:51 EDTGMGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
16:28 EDTGMAppaloosa Management gives quarterly update on stakes
Subscribe for More Information
16:01 EDTCSCOOptions Update; May 15, 2015
iPath S&P 500 VIX Short-Term Futures down 20c to 20.06 Option volume leaders: AAPL BAC FB NFLX TWTR BABA CSCO TSLA MU GILD T MSFT AMZN MCD
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
May 14, 2015
16:00 EDTCSCOOptions Update; May 14, 2015
Subscribe for More Information
14:05 EDTCSCOAnalysts clash on Cisco outlook after results
Subscribe for More Information
14:01 EDTCSCOFireEye currently unwilling to consider sale, Re/code reports
After Cisco (CEO) John Chambers said last night on the company Q3 conference call that he "wouldn't bet on" the rumor that his company was targeting an acquisition of FireEye (FEYE), Re/code's Arik Hesseldahl added that FireEye is not for sale in any case. The security company's management would not be willing to entertain takeover offers before it reaches $1B in annual revenue, sources familiar with the matter told Hesseldahl. Reference Link
11:43 EDTGMU.S. appeals court dismisses UAW retiree benefit suit, Reuters reports
Subscribe for More Information
10:00 EDTCSCOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:34 EDTCSCOActive equity options trading on open
Subscribe for More Information
09:12 EDTCSCOCisco deferred revenue strong, says SunTrust
After Cisco provided lower than expected Q4 revenue guidance, SunTrust says that the company's deferred revenue was strong, suggesting that its outlook is better than the guidance indicates. SunTrust keeps a Buy rating on the shares.
09:03 EDTGMGeneral Motors to invest $1B in Warren Technical Center campus
Subscribe for More Information
07:19 EDTCSCOCisco downgraded to Neutral on valuation at Sterne Agee CRT
Subscribe for More Information
07:11 EDTCSCOOptions expected to be active
Subscribe for More Information
07:11 EDTCSCOCisco tone 'quite bullish,' says Stifel
Subscribe for More Information
07:06 EDTCSCOCisco downgraded to Neutral from Buy at Sterne Agee CRT
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use